Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
HUSQVARNA GROUP: INTERIM REPORT JANUARY - MARCH 2024PR Newswire
Volvo Cars reports 8 per cent increase in Q1 2024 core operating profit to SEK 6.8 billionPR Newswire
Air Liquide continues its trajectory with another solid quarter, combining sales growth, performance improvement and investment momentumBusiness Wire
EQS-News: AMAG Austria Metall AG: Challenging environment influences quarterly resultEQS Newswire
u-blox reports its first quarter 2024 trading updateEQS Newswire
Elliptic Labs Shipping Its AI Software Platform on Lenovo’s Newest ThinkPad™ P Series Workstation LaptopsBusiness Wire
EQS-Adhoc: Dexus Finance Pty Limited: Appointment of non-executive directorEQS Newswire
GenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug DiscoveryPR Newswire
Information financière du premier trimestre 2024: Bon début d'année GlobeNewswire
Reminder: Unifiedpost Group Strategy Update Presentation on 30 April 2024GlobeNewswire
Vopak reports strong Q1 2024 results and increases FY 2024 outlookGlobeNewswire
Melexis Q1 2024 resultaten – Omzet van 241.8 miljoen EUR voor het eerste kwartaalGlobeNewswire
Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic UpdatesGlobeNewswire
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19GlobeNewswire
BioSenic reporte son assemblée générale annuelle des actionnaires et fournit des chiffres financiers temporaires non-audités pour 2023GlobeNewswire
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceGlobeNewswire
Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024GlobeNewswire
[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Quartal um 2% (CER); beide Divisionen Pharma und Diagnostics wachsen im hohen einstelligen Bereich ohne COVID-19-ProdukteGlobeNewswire
Norsk Hydro: Resilient in weak markets, positioned for growthGlobeNewswire
Norsk Hydro: Robust i et svakt marked, posisjonert for vekst GlobeNewswire
RNS announcements are delayed by up to an hour.
...